IMI launches project to use 'real life data' in drug development
This article was originally published in SRA
Executive Summary
The Innovative Medicines Initiative has launched a new €16.3m funded EU project called GETREAL which will work towards incorporating real-life clinical data into drug development1. The goal is to help health technology assessment (HTA) bodies decide how best to grant patients access to new treatments, and through this assist pharmaceutical companies in making better decisions during drug development.